OKYO Pharma Limited (OKYO)
NASDAQ: OKYO · Real-Time Price · USD
1.600
+0.010 (0.63%)
At close: May 19, 2026, 4:00 PM EDT
1.610
+0.010 (0.63%)
After-hours: May 19, 2026, 4:04 PM EDT
OKYO Pharma Employees
OKYO Pharma had 4 employees as of March 31, 2025. The number of employees increased by 1 or 33.33% compared to the previous year.
Employees
4
Change (1Y)
1
Growth (1Y)
33.33%
Revenue / Employee
n/a
Profits / Employee
-$1,153,335
Market Cap
83.97M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 4 | 1 | 33.33% |
| Mar 31, 2024 | 3 | -5 | -62.50% |
| Mar 31, 2023 | 8 | 1 | 14.29% |
| Mar 31, 2022 | 7 | 1 | 16.67% |
| Mar 31, 2021 | 6 | 2 | 50.00% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 213 |
| Pelthos Therapeutics | 92 |
| Fortress Biotech | 78 |
| PolyPid | 75 |
| Rani Therapeutics Holdings | 71 |
| Biomea Fusion | 41 |
| eXoZymes | 32 |
| Oncolytics Biotech | 29 |
OKYO News
- 16 hours ago - OKYO Expands Scientific Advisory Board with the Appointment of International Expert Marta Sacchetti, MD, PhD - GlobeNewsWire
- 20 days ago - OKYO CEO and CSO to Present and Leadership Team to Participate at Upcoming Scientific Conferences in May - GlobeNewsWire
- 6 weeks ago - OKYO Pharma Announces Scientific Advisory Board Meeting and Urcosimod Data Presentation During ASCRS Annual Meeting - GlobeNewsWire
- 2 months ago - OKYO Pharma Announces Chairman and Founder Acquires Shares - GlobeNewsWire
- 2 months ago - Okyo Pharma director John Brancaccio acquires 5,000 shares - TheFly
- 2 months ago - OKYO Pharma Announces Director Acquires Shares - GlobeNewsWire
- 2 months ago - Okyo Pharma CDO, director acquire shares - TheFly
- 2 months ago - OKYO Pharma Announces Chief Development Officer and Director Acquires Shares - GlobeNewsWire